{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Oral+Manifestations&page=16", "query": { "condition": "Oral Manifestations", "page": 16 }, "page_size": 10 }, "pagination": { "page": 16, "page_size": 10, "total_count": 479, "total_pages": 48, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Oral+Manifestations&page=17&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Oral+Manifestations&page=15&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T16:39:34.843Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00889486", "title": "Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gastroparesis", "Diabetes Mellitus" ], "interventions": [ { "name": "TZP-102", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tranzyme, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 92, "start_date": "2009-04", "completion_date": "2010-04", "has_results": false, "last_update_posted_date": "2012-12-11", "last_synced_at": "2026-10-14T16:39:34.843Z", "location_count": 11, "location_summary": "Long Beach, California • Los Angeles, California • San Francisco, California + 8 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Anderson", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00889486" }, { "nct_id": "NCT00892203", "title": "Efficacy and Safety of BGG492 in the Treatment of Migraine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "BGG492", "type": "DRUG" }, { "name": "Sumatriptan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 75, "start_date": "2009-04", "completion_date": "2010-08", "has_results": false, "last_update_posted_date": "2020-12-17", "last_synced_at": "2026-10-14T16:39:34.843Z", "location_count": 2, "location_summary": "Glendale, California • Paramount, California", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Paramount", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00892203" }, { "nct_id": "NCT01268670", "title": "The Addition of Oral Analgesics to LET During Laceration Repair", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Laceration", "Pain" ], "interventions": [ { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Children's Hospitals and Clinics of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "10 Years", "sex": "ALL", "summary": "4 Years to 10 Years" }, "enrollment_count": 150, "start_date": "2012-07", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-07-31", "last_synced_at": "2026-10-14T16:39:34.843Z", "location_count": 1, "location_summary": "Minneapolis and Saint Paul, Minnesota", "locations": [ { "city": "Minneapolis and Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01268670" }, { "nct_id": "NCT06601218", "title": "Impact of Daily Oral Cannabis Doses in Patients With Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cancer", "Cancers, Pain" ], "interventions": [ { "name": "Oral cannabis low THC", "type": "DRUG" }, { "name": "Placebo Comparator", "type": "DRUG" }, { "name": "Oral cannabis high THC", "type": "DRUG" }, { "name": "Oral cannabis THC/CBD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shanna Babalonis, PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2025-06-17", "completion_date": "2030-12-01", "has_results": false, "last_update_posted_date": "2026-07-15", "last_synced_at": "2026-10-14T16:39:34.843Z", "location_count": 1, "location_summary": "Lexington, Kentucky", "locations": [ { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT06601218" }, { "nct_id": "NCT00020618", "title": "Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "morphine sulfate", "type": "DRUG" }, { "name": "quality-of-life assessment", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2001-03", "completion_date": "2004-02", "has_results": false, "last_update_posted_date": "2013-07-18", "last_synced_at": "2026-10-14T16:39:34.843Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00020618" }, { "nct_id": "NCT02687451", "title": "Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Post-Operative Pain", "Acute Pain" ], "interventions": [ { "name": "Oxymorphone HCl", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Endo USA Inc., a Keenova Therapeutics Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "2 Years", "sex": "ALL", "summary": "0 Years to 2 Years" }, "enrollment_count": 28, "start_date": "2016-04", "completion_date": "2020-09-15", "has_results": true, "last_update_posted_date": "2021-10-26", "last_synced_at": "2026-10-14T16:39:34.843Z", "location_count": 3, "location_summary": "Durham, North Carolina • Dallas, Texas • Houston, Texas", "locations": [ { "city": "Durham", "state": "North Carolina" }, { "city": "Dallas", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02687451" }, { "nct_id": "NCT03108079", "title": "Bladder Morphology Using 2 Different Catheter Designs", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Urologic Injuries", "Urologic Diseases", "Bladder Infection", "Urinary Tract Infections", "Mucosal Inflammation", "Mucosal Infection", "Bladder Injury", "Catheter-Related Infections", "Catheter Complications", "Catheter; Infection (Indwelling Catheter)", "Pelvic Floor Disorders", "Urinary Incontinence" ], "interventions": [ { "name": "Cystosure Urinary Access System", "type": "DEVICE" }, { "name": "Foley Catheter", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "The Pelvic Floor Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "21 Years to 70 Years · Female only" }, "enrollment_count": 3, "start_date": "2017-04", "completion_date": "2017-06", "has_results": false, "last_update_posted_date": "2017-04-12", "last_synced_at": "2026-10-14T16:39:34.843Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03108079" }, { "nct_id": "NCT00607542", "title": "Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Spasticity", "Cerebral Palsy" ], "interventions": [ { "name": "baclofen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "2 Years to 16 Years" }, "enrollment_count": 61, "start_date": "2008-11", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2011-12-06", "last_synced_at": "2026-10-14T16:39:34.843Z", "location_count": 11, "location_summary": "Chicago, Illinois • New Orleans, Louisiana • Baltimore, Maryland + 8 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Saint Paul", "state": "Minnesota" }, { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00607542" }, { "nct_id": "NCT05103202", "title": "Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cervical Dystonia", "Blepharospasm", "Limb Dystonia", "Hemifacial Spasm", "Spasticity, Muscle", "Fragments of Torsion Dystonia" ], "interventions": [], "intervention_types": [], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 105, "start_date": "2021-11-04", "completion_date": "2022-06-14", "has_results": false, "last_update_posted_date": "2022-06-30", "last_synced_at": "2026-10-14T16:39:34.843Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05103202" }, { "nct_id": "NCT04252586", "title": "A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rett Syndrome", "RTT" ], "interventions": [ { "name": "GWP42003-P", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Years to 18 Years" }, "enrollment_count": 21, "start_date": "2020-02-28", "completion_date": "2021-06-09", "has_results": true, "last_update_posted_date": "2022-08-08", "last_synced_at": "2026-10-14T16:39:34.843Z", "location_count": 14, "location_summary": "Birmingham, Alabama • La Jolla, California • Aurora, Colorado + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04252586" } ] }